Furthermore, our case demonstrates that despite prior reports of a poor prognosis when there is co‐occurrence of CRMP5 antibodies, aggressive treatment with immunosuppression and cancer‐directed therapy can result in a dramatic recovery. Here, DPYSL5 is linked to cancer.